Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Change in Inventory (2024 - 2025)

Historic Change in Inventory for Madrigal Pharmaceuticals (MDGL) over the last 2 years, with Q3 2025 value amounting to $5.8 million.

  • Madrigal Pharmaceuticals' Change in Inventory rose 25423.01% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.6 million, marking a year-over-year increase of 59537.58%. This contributed to the annual value of $34.1 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Madrigal Pharmaceuticals reported Change in Inventory of $5.8 million as of Q3 2025, which was up 25423.01% from $8.3 million recorded in Q2 2025.
  • Over the past 5 years, Madrigal Pharmaceuticals' Change in Inventory peaked at $25.4 million during Q4 2024, and registered a low of $854000.0 during Q1 2024.